Darmstadt, Germany

Johannes Sombroek


Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 39(Granted Patents)


Location History:

  • Darmstadt-Eberstadt, DE (1988)
  • Darmstadt, DE (1981 - 2000)

Company Filing History:


Years Active: 1981-2000

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Johannes Sombroek

Introduction

Johannes Sombroek is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmacology, particularly through his work on imidazopyridines. With a total of 8 patents, Sombroek's innovations have the potential to impact the treatment of various medical conditions.

Latest Patents

Sombroek's latest patents focus on imidazopyridine derivatives and their pharmacologically acceptable salts. These compounds exhibit antagonistic properties towards angiotensin II, which can be utilized in the treatment of hypertension, aldosteronism, and cardiac insufficiency. His work in this area demonstrates a commitment to advancing medical therapies and improving patient outcomes.

Career Highlights

Throughout his career, Sombroek has worked with prominent companies in the pharmaceutical industry, including Merck Patent Gesellschaft mit beschränkter Haftung and Merck Patent GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical science.

Collaborations

Sombroek has collaborated with esteemed colleagues such as Peter Raddatz and Claus J Schmitges. These partnerships have likely fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in pharmacology.

Conclusion

Johannes Sombroek's contributions to the field of pharmacology through his patents on imidazopyridines highlight his role as an influential inventor. His work not only showcases his innovative spirit but also holds promise for improving treatments for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…